11 days old

Senior Product Manager

Avadel Management Corporation
Chesterfield, MO 63005
Apply Now
Apply on the Company Site
  • Job Code

About Avadel Pharmaceuticals plc

Avadel (AVDL) is a publicly traded specialty global pharmaceutical company with US headquarters located in the St. Louis, MO area and international operations based in the Dublin, Ireland area. For more information, please visit www.avadel.com.

At Avadel, we are passionately committed to providing solutions for overlooked and unmet medical needs through patient-focused, innovative products. We are thoughtful in our approach to identifying patient needs and finding better ways to serve them. Our organization fosters an entrepreneurial and determined atmosphere, where purpose, innovation, integrity and collaboration come together to provide new impactful treatment options for patients and their healthcare providers.

Our approach to developing new medicines is based on applying proprietary controlled-release technology that improves the way drugs are dosed and released. We are currently focused on the development and potential FDA approval of our lead candidate, FT218.

Avadels FT218 is an investigational, once-nightly, extended-release formulation of sodium oxybate intended to treat excessive daytime sleepiness (EDS) and cataplexy in patients suffering from narcolepsy. Sodium Oxybate is currently the standard of care for the treatment of excessive daytime sleepiness (EDS) and cataplexy in patients suffering from narcolepsy. However, the currently approved sodium oxybate formulations require two nightly doses - one dose at bedtime and the second dose 2.5-4 hours later, in the middle of the night.

Once-nightly FT218 has been granted Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for the treatment of narcolepsy. The designation was granted on the plausible hypothesis that once-nightly FT218 may be clinically superior to a formulation of sodium oxybate that is already approved by the FDA for the same indication. In particular, once-nightly FT218 may be safer due to ramifications associated with the dosing regimen of the currently marketed twice-nightly product. The twice-nightly sodium oxybate market is valued at an estimated $1.8 billion annually. Avadels market research suggests that FT218, if approved by the FDA, has the potential to command a market leading share of the oxybate-based narcolepsy treatment market. FT218 currently has patent protection until at least 2037 with additional patent applications pending that could extend that date beyond 2040.

On April 27, 2020, we announced positive topline results from our pivotal phase 3 REST-ON Trial of once-nightly FT218 for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy. On December 16, 2020, we announced the submission of our New Drug Application (NDA) in the United States for FT-218. On March 1, 2021, we announced FDA acceptance of the FT218 NDA and a target action PDUFA date of October 15, 2021.

We are a small team that will be growing a lot and we have a lot of work to do in building towards our best-in-class team to support commercialization of FT-218, if approved. We are seeking bright people who want to roll up their sleeves, build our company together and make an impact so that we can help people suffering from narcolepsy.

Position Summary:

The Senior Product Manager will be a critical member of the brand team responsible for launching FT218 for the treatment of narcolepsy. This position will support the brand team in the execution of the marketing plan to drive awareness and adoption for once-nightly FT218, primarily focused on patient audiences.

The Senior Product Manager will support other team members including the Executive Director Patient & Payer, Marketing Director HCPs, Associate Director, Digital Marketing and the VP of Marketing to deliver on tactical execution to achieve brand objectives. This individual will collaborate within the marketing team to contribute to aspects of brand strategy and to the development and execution of the tactics for unbranded and branded patient campaigns. The Senior Product Manager will own execution for key elements of the DTP campaign with marketing team direction and will also engage with narcolepsy patient advocates and advisors on a regular basis. In addition, they will work across Marketing to coordinate support of Field Sales Training and HCP Speaker Programs, to provide cross-brand exposure and growth.

This is a unique opportunity for a patient-focused marketeer to be a core team member on an exciting pharmaceutical launch in the orphan/rare disease area to help people living with narcolepsy as a lifetime, chronic CNS condition.

Essential Functions:

  • Support the marketing team and launch strategy through the execution of the marketing plans for patient/consumer audiences.
  • Assist in the development and deployment of unbranded disease awareness market conditioning tactics and branded patient support & adherence program tactics to deliver a best-in-class patient experience and achieve brand objectives.
  • Execute key patient-focused marketing tactics including unbranded and branded websites for patients, SEM, social media, affiliate marketing, email marketing, etc.
  • Collaborate with external agency partners to execute tactics effectively on time and report campaign metrics.
  • Collaborate with Patient Service Team to deliver content and patient support program offerings that enhance the patient experience and support adherence on brand.
  • Project manage marketing deliverables through stages of content development, promotional/medical/legal/regulatory review, production, deployment, evaluation and optimization to meet objectives on time.
  • Engage with key Patient Advocacy partners and patient advisors to get patient feedback / input into the development of education and support materials for people with narcolepsy.
  • Work with Marketing colleagues and Commercial Operations to coordinate support of Field Sales Training and HCP Speaker Programs
  • Bring an innovative, entrepreneurial attitude and combine out-of-the box ideas with established patient marketing tactics to identify efficient and appropriate channels for engaging with patient audiences on disease education and branded messaging in a dynamic environment (including post-COVID landscape)
  • Collaborate with internal stakeholders including marketing, market insights & analytics, patient services, regulatory / compliance and others.
  • Be a pivotal member of the Brand team.
  • Drive the spirit of ONE Team across all functions to support a full team approach to focus on our patients and customers as our top priority.

Education, Experience, & Skills:

  • Bachelors Degree required, preferably in the fields of Marketing, Communications, or a life-science related discipline.
  • Minimum 3 years of experience in pharmaceutical/biotechnology marketing, with experience successfully executing marketing tactics.
  • Patient/direct-to-consumer campaign experience is highly desirable, especially in rare or orphan disease.
  • Prior experience engaging and collaborating with Patient Advocacy partners or working with a patient network is a plus.
  • Be flexible and adept to work in a fast-paced, start-up environment with the ability to take initiative and solve problems to build a best-in-class launch.
  • Quickly develop narcolepsy disease-state understanding, competitive landscape knowledge, and FT218 market insights to get up to speed on the strategic foundation and the action plan.
  • Be empathetic to narcolepsy patients and their caregivers; understand their needs and communicate compelling, sensitive patient messaging.
  • Ability to collaborate effectively in an evolving cross-functionally matrixed structure with some ambiguity.
  • Set an example for others in good business conduct and adherence with applicable laws, regulations, rules and codes (especially including HIPAA compliance and patient privacy)
  • Proven ability to work under pressure and prioritize work to achieve positive results.
  • Team player who is able to have fun!

Avadel is an Equal Opportunity Employer


Posted: 2021-07-19 Expires: 2021-08-20

Before you go...

Our free job seeker tools include alerts for new jobs, saving your favorites, optimized job matching, and more! Just enter your email below.

Share this job:

Senior Product Manager

Avadel Management Corporation
Chesterfield, MO 63005

Join us to start saving your Favorite Jobs!

Sign In Create Account
Powered ByCareerCast